Naloxone Market
According to Intent Market Research, the Naloxone Market is expected to grow from USD 1.3 billion in 2024-e at a CAGR of 12.2% to touch USD 2.6 billion by 2030. The Naloxone Market is dominated by key players such as Hikma Pharmaceuticals, Amgen Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Indivior Plc, Johnson & Johnson, Adapt Pharma, Sandoz (Novartis), Mallinckrodt Pharmaceuticals, Opiant Pharmaceuticals, Insys Therapeutics, Eli Lilly and Company, AstraZeneca, Pfizer Inc., Alkermes Plc